当前位置:首页 - 行情中心 - 诺泰生物(688076) - 财务分析 - 现金流量表

诺泰生物

(688076)

  

流通市值:118.75亿  总市值:118.75亿
流通股本:3.15亿   总股本:3.15亿

现金流量表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金502,428,349.281,430,689,620.31,015,126,130.88684,948,825.39
收到的税费返还47,342,555.6874,170,565.7558,785,398.2344,610,713.11
收到其他与经营活动有关的现金35,074,830.2176,607,176.9163,506,679.3316,140,803.26
经营活动现金流入的平衡项目0000
经营活动现金流入小计584,845,735.171,581,467,362.961,137,418,208.44745,700,341.76
购买商品、接受劳务支付的现金156,903,156.88572,361,709.88390,235,928.04241,850,967.08
支付给职工以及为职工支付的现金134,326,881.72307,985,771.02232,893,686.75159,225,514.61
支付的各项税费19,922,788.8592,735,025.661,370,108.2834,345,339.39
支付其他与经营活动有关的现金128,316,255.07208,268,778.58185,614,187.49111,845,877.87
经营活动现金流出的平衡项目0000
经营活动现金流出小计439,469,082.521,181,351,285.08870,113,910.56547,267,698.95
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额145,376,652.65400,116,077.88267,304,297.88198,432,642.81
二、投资活动产生的现金流量:
收回投资收到的现金470,174,5001,503,113,5001,240,000,000775,000,000
取得投资收益收到的现金708,972.031,068,492.311,181,455.59596,992.6
处置固定资产、无形资产和其他长期资产收回的现金净额-3,981,923.261,300,951887,951
收到的其他与投资活动有关的现金-192,216.33--
投资活动现金流入的平衡项目0000
投资活动现金流入小计470,883,472.031,508,356,131.91,242,482,406.59776,484,943.6
购建固定资产、无形资产和其他长期资产支付的现金353,142,851.961,090,121,833.32650,245,774.41328,154,212.17
投资支付的现金302,169,3001,811,113,5001,432,500,0001,000,000,000
支付其他与投资活动有关的现金-312,972--
投资活动现金流出的平衡项目0000
投资活动现金流出小计655,312,151.962,901,548,305.322,082,745,774.411,328,154,212.17
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-184,428,679.93-1,393,192,173.42-840,263,367.82-551,669,268.57
三、筹资活动产生的现金流量:
吸收投资收到的现金-22,978,687.522,978,687.522,978,687.5
取得借款收到的现金274,792,998.631,698,192,220.881,075,334,696.58649,950,000
收到其他与筹资活动有关的现金-100,000,000--
筹资活动现金流入平衡项目0000
筹资活动现金流入小计274,792,998.631,821,170,908.381,098,313,384.08672,928,687.5
偿还债务支付的现金153,296,331.12891,358,946.72528,804,586358,754,586
分配股利、利润或偿付利息支付的现金11,186,141.29118,751,746.93126,121,514.2696,694,367.6
支付其他与筹资活动有关的现金1,420,96511,305,617.615,749,093.334,284,037.01
筹资活动现金流出平衡项目0000
筹资活动现金流出小计165,903,437.411,021,416,311.26660,675,193.59459,732,990.61
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额108,889,561.22799,754,597.12437,638,190.49213,195,696.89
四、汇率变动对现金及现金等价物的影响567,791.368,344,284.541,407,296.873,273,509.77
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额70,405,325.3-184,977,213.88-133,913,582.58-136,767,419.1
加:期初现金及现金等价物余额492,555,518.93677,532,732.81677,532,732.81677,532,732.81
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额562,960,844.23492,555,518.93543,619,150.23540,765,313.71
补充资料:
净利润-399,818,448.38-231,765,163.69
资产减值准备-36,426,468.1-10,140,579.59
固定资产和投资性房地产折旧-192,404,246.24-89,374,484.02
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-192,404,246.24-89,374,484.02
无形资产摊销-10,200,764.56-5,306,256.26
长期待摊费用摊销-7,013,008.5-3,167,297.25
处置固定资产、无形资产和其他长期资产的损失--496,916.25-0
固定资产报废损失-9,701,386.97-1,960,655.48
公允价值变动损失-2,791,811.68-3,133,714.68
财务费用-26,071,774.67-8,118,773.74
投资损失--1,068,492.31-463,054.67
递延所得税--42,538,497.98--23,612,953.92
其中:递延所得税资产减少--40,982,928.68--22,832,474.25
递延所得税负债增加--1,555,569.3--780,479.67
存货的减少--243,292,791.72--51,561,123.97
经营性应收项目的减少--348,970,741.52--207,045,786.38
经营性应付项目的增加-291,167,568.84-85,489,519.26
其他-32,630,078.08-25,838,292.75
现金的期末余额-492,555,518.93-540,765,313.71
减:现金的期初余额-677,532,732.81-677,532,732.81
公告日期2025-04-232025-04-232024-10-232024-08-23
审计意见(境内)带强调事项段的无保留意见
TOP↑